Compile Data Set for Download or QSAR
maximum 50k data
Found 129 Enz. Inhib. hit(s) with all data for entry = 11227
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601457(2-[4-(Methylamino)phenyl]-N-[(3S)-2-oxo-5-phenyl-1...)
Affinity DataEC50:  35nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601458(2-(2-Fluorophenyl)-N- [(3S)-2-oxo-5-phenyl- 1,3-di...)
Affinity DataEC50:  39nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601459(N-[(3S)-9-fluoro-2-oxo- 5-phenyl-1,3-dihydro- 1,4-...)
Affinity DataEC50:  90nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601460(2-(2,4-difluorophenyl)- N-[(3S)-2-oxo-5- phenyl-1,...)
Affinity DataEC50:  62nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601461(2-(2,4-Difluorophenyl)- N-[(3S)-9-fluoro-2-oxo- 5-...)
Affinity DataEC50:  39nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601463(2-(2,5-Difluorophenyl)- N-[(3S)-2-oxo-5- phenyl-1,...)
Affinity DataEC50:  94nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601465(2-(2,5-Difluorophenyl)- N-[(3S)-9-fluoro-2-oxo- 5-...)
Affinity DataEC50:  107nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601466(2-(2-Fluoro-5- methoxyphenyl)-N- [(3S)-9-fluoro-2-...)
Affinity DataEC50:  54nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601467(2-(2-Fluoro-3- methoxyphenyl)-N- [(3S)-9-fluoro-2-...)
Affinity DataEC50:  73nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601468(2-(2-Chlorophenyl)-N- [(3S)-9-fluoro-2-oxo-5- phen...)
Affinity DataEC50:  77nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601469(2-(1-Methyl-2,3-dihydroindol-6-yl)-N-[(3S)-2-oxo-5...)
Affinity DataEC50:  89nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601470(N-[(3S)-2-oxo-5- phenyl-1,3-dihydro- 1,4-benzodiaz...)
Affinity DataEC50:  153nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601472(N-[(3S)-2-Oxo-5- phenyl-1,3-dihydro- 1,4-benzodiaz...)
Affinity DataEC50:  94nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601473(2-(2-Fluoro-4- methoxyphenyl)-N- [(3S)-2-oxo-5- ph...)
Affinity DataEC50:  41nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601475(2-(2-Fluoro-4- propan-2- yloxyphenyl)-N- [(3S)-2-o...)
Affinity DataEC50:  91nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601476(2-[2-Fluoro-4- (methylamino)phe- nyl]-N-[(3S)-2-ox...)
Affinity DataEC50:  18nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601477(N-[(3S)-9-Fluoro-2- oxo-5-phenyl-l,3- dihydro-1,4-...)
Affinity DataEC50:  90nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601478(N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-be...)
Affinity DataEC50:  28nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601479(N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-be...)
Affinity DataEC50:  31nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601480(6-Chloro-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihyd...)
Affinity DataEC50:  114nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601482(6-Chloro-2- methyl-N-[(3S)- 2-oxo-5-phenyl- 1,3-di...)
Affinity DataEC50:  147nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601483(2-(2- Fluorophenyl)-5- methyl-N-[(3S)- 2-oxo-5-phe...)
Affinity DataEC50:  33nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601484(N-[(3S)-9- Fluoro-2-oxo-5- phenyl-1,3- dihydro-1,4...)
Affinity DataEC50:  21nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601485(N-[(3S)-9- Fluoro-2-oxo-5- phenyl-1,3- dihydro-1,4...)
Affinity DataEC50:  104nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601486(2-(2-Fluoro-5- methylphenyl)-N-[(3S)- 2-oxo-5-phen...)
Affinity DataEC50:  116nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601488(2-(2-Fluoro-5- methylphenyl)-N-[(3S)- 9-fluoro-2-o...)
Affinity DataEC50:  53nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601493(2-(5-Chloropyridin-3- yl)-N-[(3S)-2-oxo-5- phenyl-...)
Affinity DataEC50:  61nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601494(2-(5-Chloropyridin-3- yl)-N-[(3S)-9-fluoro-2- oxo-...)
Affinity DataEC50:  41nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601494(2-(5-Chloropyridin-3- yl)-N-[(3S)-9-fluoro-2- oxo-...)
Affinity DataEC50:  66nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601495(2-(6- Cyclopropylpyridin-3- yl)-N-[(3S)-2-oxo-5- p...)
Affinity DataEC50:  72nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601496(2-(6- Cyclopropylpyridin-3- yl)-N-[(3S)-9-fluoro-2...)
Affinity DataEC50:  62nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601497(2-(5- Cyclopropylpyridin-3- yl)-N-[(3S)-2-oxo-5- p...)
Affinity DataEC50:  96nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601498(2-(2-Fluoro-5- methylpyridin-3-yl)-N- [(3S)-9-fluo...)
Affinity DataEC50:  86nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601499(2-(2- Fluorophenyl)-6- methyl-N-[(3S)- 2-oxo-5-phe...)
Affinity DataEC50:  29nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601500(N-[(3S)-9- Fluoro-2-oxo-5- phenyl-1,3- dihydro-1,4...)
Affinity DataEC50:  23nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601501(2-(2,4- Difluorophenyl)- 5-methyl-N- [(3S)-2-oxo-5...)
Affinity DataEC50:  29nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601502(2-(2,4- Difluorophenyl)- N-[(3S)-9- fluoro-2-oxo-5...)
Affinity DataEC50:  27nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601503(2-(2- Fluorophenyl)-7- methyl-N-[(3S)- 2-oxo-5-phe...)
Affinity DataEC50:  39nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601504(N-[(3S)-9- Fluoro-2-oxo-5- phenyl-1,3- dihydro-1,4...)
Affinity DataEC50:  27nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601505(2-(2- Fluorophenyl)-5- (morpholin-4- yl)-N-[(3S)-2...)
Affinity DataEC50:  62nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601506(N-[(3S)-9- Fluoro-2-oxo-5- phenyl-1,3- dihydro-1,4...)
Affinity DataEC50:  51nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601507(2-(2- Fluorophenyl)- N-[(3S)-2-oxo-5- phenyl-1,3- ...)
Affinity DataEC50:  80nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601508(2-(2,3-Difluorophenyl)-N-[(3S)-9-fluoro-2-oxo-5-ph...)
Affinity DataEC50:  41nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601509(2-(2,3- Difluorophenyl)-N- [(3S)-2-oxo-5-phenyl- 1...)
Affinity DataEC50:  60nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601510(2-(2,6- Difluorophenyl)-N- [(3S)-9-fluoro-2-oxo- 5...)
Affinity DataEC50:  87nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601511(2-(2-Fluoro-4- pyrrolidin-1- ylphenyl)-N-[(3S)-2- ...)
Affinity DataEC50:  103nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601512(6-Methyl-N-[(3S)-2- oxo-5-phenyl-1,3- dihydro-1,4-...)
Affinity DataEC50:  94nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601513(N-[(3S)-9-fluoro-2- oxo-5-phenyl-1,3- dihydro-1,4-...)
Affinity DataEC50:  101nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601514(2-[6-(Cyclopropylamino)-2-fluoropyridin-3-yl]-N-[(...)
Affinity DataEC50:  13nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNucleoprotein(Human respiratory syncytial virus A (strain A2))
Pfizer

US Patent
LigandPNGBDBM601515(2-(6- Methylpyridin-3- yl)-N-[(3S)-2- oxo-5-phenyl...)
Affinity DataEC50:  100nMAssay Description:Hep-G2 cells (ECACC, 85011430) were passaged in flasks and seeded in 24-well plates in DMEM containing antibiotics and supplemented with 10% FBS. Dur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 129 total ) | Next | Last >>
Jump to: